ARCHIVES

In Brief: No End Of The Year Hassle His Time – NCI Full Appropriation for FY 1977 Released

This article is from The Cancer Letter archive.

Vol. 02 No. 47 | November 19, 1976

Download PDF Visit The Full Archive

Related Articles

The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken.

May 7, 2004

Five NCAB members complete terms.

February 20, 2004

Salick Raises Nearly $50 Million, Proceeding With FCC Development

June 6, 1986

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

October 9, 1992

Prospects Fading for Funding More CCOPsIn FY ’83; Return to Groups Of Money From Satellites Going To New Programs

July 29, 1983

Members of Congress say that won’t work.

September 30, 2005